![]() |
![]() |
Teisinis statusas
Patentas galioja
(51) | INT.CL. | A61K 39/02 | (2006.01) |
A61K 39/00 | (2006.01) | ||
C08B 37/00 | (2006.01) | ||
A61K 39/108 | (2006.01) | ||
A61P 31/04 | (2006.01) | ||
A61K 47/64 | (2017.01) |
(11) | Patento numeris | 3341016 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 16760616.9 |
Europos patento paraiškos padavimo data | 2016-08-24 | |
(97) | Europos patento paraiškos paskelbimo data | 2018-07-04 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2023-06-07 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2016/048278 |
Data | 2016-08-24 |
(87) | Numeris | WO 2017/035181 |
Data | 2017-03-02 |
(30) | Numeris | Data | Šalis |
201562209091 P | 2015-08-24 | US | |
201562210655 P | 2015-08-27 | US |
(72) |
POOLMAN, Jan, Theunis , NL
JACQUEMYN, Bert , BE
ABBANAT, Darren, Robert , US
YON, Patricia, Ibarra , CH
HERMANS, Peter, Wilhelmus, Maria , NL
KOWARIK, Michael, Thomas , CH
WETTER, Michael, Lukas , CH
KEMMLER, Stefan, Jochen , CH
HAUPTLE, Micha, Andres , CH
GAMBILLARA, Veronica , CH
MALLY, Manuela , CH
|
(73) |
GlaxoSmithKline Biologicals S.A. ,
Rue de l'Institut, 89, 1330 Rixensart,
BE
Janssen Pharmaceuticals, Inc. , 1125 Trenton-Harbourton Road, Titusville, NJ 08560, US |
(54) | METHODS AND COMPOSITIONS FOR IMMUNE PROTECTION AGAINST EXTRA-INTESTINAL PATHOGENIC E. COLI |
METHODS AND COMPOSITIONS FOR IMMUNE PROTECTION AGAINST EXTRA-INTESTINAL PATHOGENIC E. COLI |